Huizhou Fuxin Microelectronics Co., Ltd. – Trademark Portfolio

Entity Type: 16

Huizhou Fuxin Microelectronics Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AUREVELLA. The owner is based in Huizhou, Guangdong.

Room 02, 14F, Unit 1, Bldg 15, Phase II

Mingzuo Garden, Baiyunkeng, Huiyang Dist

Huizhou, Guangdong 516211 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AUREVELLA
AUREVELLA
Registered 2025

Trademark Classifications

Huizhou Fuxin Microelectronics Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Huizhou Fuxin Microelectronics Co., Ltd. have?

Huizhou Fuxin Microelectronics Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Huizhou Fuxin Microelectronics Co., Ltd. file in?

Huizhou Fuxin Microelectronics Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Huizhou Fuxin Microelectronics Co., Ltd.'s most well-known trademarks?

Huizhou Fuxin Microelectronics Co., Ltd.'s registered trademark portfolio includes well-known marks such as AUREVELLA. These are among 1 currently registered trademark in the portfolio.

What is Huizhou Fuxin Microelectronics Co., Ltd.'s trademark registration success rate?

Huizhou Fuxin Microelectronics Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.